ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction

Apr 9, 2024
Guest
Javed Butler
Guest
Sun Moon Kim
Cardiologists Javed Butler and Sun Moon Kim discuss EMPACT-MI trial results on heart failure risk post-myocardial infarction. They explore misconceptions on EF percentages, diuretics, and benefits of SGLT2 inhibitors. Real-world evidence shapes future treatment strategies.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 5min
2
Inclusion Criteria for Heart Failure Signs and Mismatch in Heart Failure Risk Reduction vs. Mortality Benefit
05:11 • 3min
3
Navigating the Implications of SGLT2 Inhibitors Post-Acute Myocardial Infarction
08:28 • 3min